argyrotsipi/train-dataset huggingface dataset:
Prescription Charges: Asthma — House of Commons, 2019-03-26
Topic: Health
Caroline Julia Dinenage (Conservative, Centre-right): Almost 90% of prescription items dispensed in the community in England are free of charge. That includes medicines for the treatment of asthma. The fact is that people who, like me, suffer from asthma and need those prescriptions have to decide, as taxpayers—as the people funding our NHS—whether we would rather contribute to those prescriptions or see the underfunding we have seen in Scotland, where GPs have been underfunded by almost £660 million over the last four years. It is a case of priorities.
Prescription Charges: Asthma — House of Commons, 2019-03-26
Topic: Health
Caroline Julia Dinenage (Conservative, Centre-right): We all miss my hon. Friend the Member for Winchester (Steve Brine), so I thank the hon. Lady for her comments Since prescription charges were introduced, Governments of all colours have decided that some patients should pay prescription charges to contribute to the cost of running the NHS, but almost 90% of prescription items are dispensed in the community free of charge, which I think the hon. Lady will agree is an enormous amount.
Orkambi — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): On 11 March, I held a meeting with all the parties to discuss how best to ensure that people with cystic fibrosis and their families can benefit from the best drugs as soon as possible. Vertex, the National Institute for Health and Care Excellence and NHS England met on Thursday and have agreed to take those discussions forward.
Orkambi — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): We are having constructive discussions—I am delighted that finally Vertex has agreed to participate in them; the parties have committed to providing the data needed for an objective assessment of the drugs in question, and I look forward to the discussions proceeding effectively.
Orkambi — House of Commons, 2019-03-26
Topic: Health
Rachel Helen Maclean (Conservative, Centre-right): A constituent of mine came to see me in my surgery. He had been born with cystic fibrosis and told me what a transformative effect the drug had had on him. He was lucky enough to be accepted on the trial, but he says we need to raise awareness because millions of people are not getting the drug. What response can the Secretary of State give to him and fellow sufferers?
Orkambi — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): My hon. Friend’s constituent is absolutely right about raising awareness of the issue and the need for these drugs. I know the impact that cystic fibrosis can have on people and of the hope that these drugs will save lives. We have made a significant offer to the pharmaceutical company, Vertex, to allow these drugs to be provided in the UK, and I very much hope we can come to an agreement.
Orkambi — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): Yes, of course I will. I understand exactly where that process has got to. It concerns a different drug from the one in the question, but it is also a very important consideration for a number of people.
Orkambi — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): I am happy to consider all options that can secure access in a way that provides value for money based on an objective assessment of what is clinically right. That is the basis of our discussions.
Orkambi — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): That is one very important consideration. Having met people suffering from cystic fibrosis and heard directly the stories they tell about the impact on their lives and how it potentially shortens their lives, I think it is very important that we find a solution, which is why I was so determined to bring the parties together.
Antimicrobial Resistance: Vaccines — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): The new five-year national action plan to tackle antimicrobial resistance contains the commitment to support more research into new and alternative treatments, including vaccines and diagnostic tests, to promote broader access to vaccines for both humans and animals.
Antimicrobial Resistance: Vaccines — House of Commons, 2019-03-26
Topic: Health
Stephen Crabb (Conservative, Centre-right): Stopping the spread of diseases such as TB by using vaccines will play a key role in tackling AMR worldwide, so what plans does my right hon. Friend have for building on the excellent work of the UK Vaccine Network, with all the funding that goes with that, to ensure continued UK leadership in vaccinology?
Antimicrobial Resistance: Vaccines — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): I am afraid that I profoundly disagree with the hon. Gentleman, who used to be so sensible. Antimicrobial resistance is a global problem and we contribute to global funds, because only by coming together as a whole world will we be able to tackle it— and that is what we are going to do.
NHS Nursing Associates — House of Commons, 2019-03-26
Topic: Health
Andrew Iain Lewer (Conservative, Centre-right): The University of Northampton successfully carried out its partnership with Northampton General Hospital in training the first wave of nursing associates in the United Kingdom, as the Secretary of State saw when he visited the hospital recently. What can he and his team do to encourage other universities and local hospitals to form partnerships to deliver similar results?
NHS Nursing Associates — House of Commons, 2019-03-26
Topic: Health
Stephen William Hammond (Conservative, Centre-right): I know that the Secretary of State enjoyed his visit, and was very impressed by what he saw. Health Education England has led the establishment of test site partnerships across England. There were 11 test sites in the first wave and a further 24 in April 2017, and the programme is now being rolled out all over the country.
Lyme Disease — House of Commons, 2019-03-26
Topic: Health
Caroline Julia Dinenage (Conservative, Centre-right): The National Institute for Health Research is supporting the study of Lyme disease by researching markers that would offer a faster and more accurate diagnosis. Meanwhile, the National Institute for Health and Care Excellence has published clinical guidance for the diagnosis and treatment of the disease for healthcare professionals.
Lyme Disease — House of Commons, 2019-03-26
Topic: Health
Hugo Swire (Conservative, Centre-right): Lyme disease is often misdiagnosed or diagnosed late, which results in widespread suffering such as joint pain, paralysis and brain damage. Will the Minister therefore join me in congratulating the charity Caudwell LymeCo, which has pledged £1 in research funding, and will her Department commission research on a better test for the disease?
Lyme Disease — House of Commons, 2019-03-26
Topic: Health
Caroline Julia Dinenage (Conservative, Centre-right): My right hon. Friend is absolutely right to raise this issue. We know that the outcome of Lyme disease depends on whether it is diagnosed and treated at an early stage. That is why my Department commissioned four separate independent systematic reviews of all the relevant literature on the diagnosis, treatment, transition and prevention of the disease, which were published in December 2017 and which assess the existing evidence for the research community, research funders and the public. We welcome all independent researchers who want to do more work on that basis.
Lyme Disease — House of Commons, 2019-03-26
Topic: Health
Caroline Julia Dinenage (Conservative, Centre-right): Most people are diagnosed and treated successfully by GPs and recover uneventfully, but in a few cases people who are diagnosed late or are not treated adequately may develop significant complications. That is why the National Institute for Health Research welcomes applications for research funds.
Lyme Disease — House of Commons, 2019-03-26
Topic: Health
Questions: Earlier this month I visited a young lady in my constituency who was living a perfectly good life but was then struck down by Lyme disease. She has not left the House in over 12 months and is in terrible pain all the time. The NHS in this country did not find a diagnosis from her blood sample; it had to be sent to Germany to get the diagnosis. An awful lot more needs to be done to help these people.
Caroline Julia Dinenage (Conservative, Centre-right): My hon. Friend is absolutely right to raise this: we do need to do more in this space, and that is why we are investing over £1 billion a year in health research through the National Institute of Health Research.
NHS Access Standards — House of Commons, 2019-03-26
Topic: Health
Questions: What assessment he has made of the implications for his Department’s policies of the conclusions of the “Clinically-led review of NHS access standards: interim report from the NHS national medical director”; and if he will make a statement.
Matthew John David Hancock (Conservative, Centre-right): It is a great pity to see the hon. Gentleman back up there on the Back Benches as he was such a force—and a rare force—for reason and progress on the Opposition Front Bench until recently Standards in the NHS should be based on clinical evidence, and NHS England’s proposals will be rigorously field-tested to gather further evidence on clinical, operational, workforce and financial implications, all with the goal of improving the quality of care.
NHS Access Standards — House of Commons, 2019-03-26
Topic: Health
Questions: What assessment he has made of the implications for his Department’s policies of the conclusions of the “Clinically-led review of NHS access standards: interim report from the NHS national medical director”; and if he will make a statement.
Matthew John David Hancock (Conservative, Centre-right): Of course, we are aiming to meet and improve against the targets, including with the injection of the extra money—£34 billion extra in cash terms over the next five years. At the same time we must make sure that the standards to which we hold the NHS are the right ones clinically for the times, and that is what this review of standards is all about.
Cervical Cancer — House of Commons, 2019-03-26
Topic: Health
Jacqueline Doyle-Price (Conservative, Centre-right): We have some of the highest HPV—human papillomavirus—vaccination rates in the world. This month we launched a major new national campaign to increase the number of women attending cervical screening across England, and throughout the NHS long-term plan we have committed to radically overhaul screening programmes and further invest in the latest technology to transform diagnosis and boost research and innovation.
Cervical Cancer — House of Commons, 2019-03-26
Topic: Health
Mary Josephine Robinson (Conservative, Centre-right): Figures from Jo’s Cervical Cancer Trust show that 200,000 women in Greater Manchester have missed their smear test, including half of women aged 25 to 29, yet we know that smear tests save lives. What are the Government doing to raise awareness of the importance of attending screening to prevent cervical cancer?
Cervical Cancer — House of Commons, 2019-03-26
Topic: Health
Jacqueline Doyle-Price (Conservative, Centre-right): My hon. Friend is right: cervical screening saves up to 5,000 lives every year, so we cannot do enough to encourage women to take advantage of the screening. It is not the most pleasant experience to go through, but it can save lives. I would encourage everyone to take advantage of the screening, and we will continue to do our best to promote it.
Cervical Cancer — House of Commons, 2019-03-26
Topic: Health
Jacqueline Doyle-Price (Conservative, Centre-right): The hon. Lady makes some excellent points and highlights those areas of the community where take-up is much lower. We need to be more imaginative about how we promote the need for screening, and in that regard I am very pleased to see the work of Jo’s Trust, and also that of the Eve Appeal to raise awareness. We can all do our bit, and I would encourage everyone to spread the word about the need to get screened.
Cervical Cancer — House of Commons, 2019-03-26
Topic: Health
Jacqueline Doyle-Price (Conservative, Centre-right): As the hon. Lady will know, we have brought that service back in-house, but we should leave no stone unturned in relation to thinking more imaginatively about how we spread the word about the need for screening. I should like to pay tribute to those celebrities who have tweeted pictures of themselves going for their smear tests, because it is only by normalising it and ensuring that everyone realises that it is something they should do that we are going to encourage take-up.
Access to GPs — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): Primary and community care are set to receive an additional £4.5 billion a year of taxpayers’ money as part of the NHS long-term plan, to ensure that we can get the best possible access to GPs.
Access to GPs — House of Commons, 2019-03-26
Topic: Health
Helen Olivia Bicknell Whately (Conservative, Centre-right): In parts of my constituency, it is very difficult for people to see their GP. For example, in the area of Park Wood there is just one GP for 4,000 patients. I welcome the extra money going into primary care that my right hon. Friend just mentioned, as well as the additional GP training places and the fact that a Kent medical school is coming our way, but we need more nurses, physios and other health professionals in primary care. What is he doing to ensure that people can see the right health professional when they need to do so?
Access to GPs — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): This is an incredibly important agenda that is close to my heart. It is at the core of the prevention of ill health to ensure that we have the right primary care services. Yes, that includes more GPs, but it also includes more of the other health professionals who support them. We have 1,000 extra non-GP clinical staff already working in general practice compared with just two years ago, but there is much more to do.
Access to GPs — House of Commons, 2019-03-26
Topic: Health
Kevin Paul Hollinrake (Conservative, Centre-right): GPs are the first line of defence against superbugs and antimicrobial resistance, and the Secretary of State is already proving to be a world leader in this area. The idea of a resistance tax has the support of other world leaders including Lord O’Neill and Dame Sally Davies. Would he consider this approach?
Access to GPs — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): I am happy to look at all approaches to how we can reduce the overuse of antibiotics in order to preserve them so that they work effectively where they are needed. Of course GPs have a role to play in that, and the number of antibiotics prescribed by GPs has fallen in recent years, but again there is much more work to do.
Access to GPs — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): That is an interesting proposition and I would be happy to talk to the hon. Gentleman more about the idea. I was in Northern Ireland last week looking at medical services there and at what we can learn, and that might be another idea.
STPs: Five-year Workforce Plans — House of Commons, 2019-03-26
Topic: Health
Stephen William Hammond (Conservative, Centre-right): Workforce is a key priority for the Government, which is why my right hon. Friend the Secretary of State asked Baroness Dido Harding to develop an interim workforce implementation plan for the spring, including a 2019-20 action plan. It is right that local leaders and clinicians should be empowered to shape the services they need, which is why NHS Improvement has written to all system leaders in England to ask for their views on the vision that is coming forward.
STPs: Five-year Workforce Plans — House of Commons, 2019-03-26
Topic: Health
Stephen William Hammond (Conservative, Centre-right): The hon. Gentleman asked a number of questions there. It is true that the NHS has recently asked all sustainability and transformation partnerships and integrated care systems to create new five-year plans by autumn 2019 setting out how they are going to transform services. He will know that mental health is a priority in the long-term plan, and that we are expanding the number of places for clinicians.
STPs: Five-year Workforce Plans — House of Commons, 2019-03-26
Topic: Health
Questions: Cancer Research UK estimates that by 2035 there will be over half a million new cancer cases—up by 150,000 a year on 2015 levels. In order to meet the Government’s ambition of diagnosing 75% of cancers at an early stage, does the Minister accept that the NHS will need a proper training and recruitment plan for its cancer workforce, which must be fully funded in the upcoming spending review?
Stephen William Hammond (Conservative, Centre-right): The hon. Gentleman is right: early diagnosis of cancer is vital for successful outcomes. The Government are absolutely committed to a cancer workforce with the skills and expertise to ensure that 75% of all cancers are diagnosed early, not just the top 10. As I have said several times, that is why we asked Baroness Dido Harding to develop a detailed workforce plan to ensure that that can be delivered.
STPs: Five-year Workforce Plans — House of Commons, 2019-03-26
Topic: Health
Questions: Cancer Research UK estimates that by 2035 there will be over half a million new cancer cases—up by 150,000 a year on 2015 levels. In order to meet the Government’s ambition of diagnosing 75% of cancers at an early stage, does the Minister accept that the NHS will need a proper training and recruitment plan for its cancer workforce, which must be fully funded in the upcoming spending review?
Stephen William Hammond (Conservative, Centre-right): My hon. Friend has been a champion of this cause for a long time, raising the matter on the Floor of the House several times. He can be assured that, as I said to the hon. Member for City of Chester (Christian Matheson), Baroness Harding has been asked to bring forward detailed plans for the cancer workforce in her implementation plan.
Topical Questions — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): We all in this House have huge admiration for the dedicated staff who work night and day to deliver world-class care to patients in our NHS. We should recognise that today marks the 75th anniversary of the publication of the White Paper on the establishment of the NHS, delivered in this House by a Conservative Minister, under a Conservative Prime Minister.
Topical Questions — House of Commons, 2019-03-26
Topic: Health
Stephen Crabb (Conservative, Centre-right): The prescription of powerful painkillers has soared, as has the number of overdoses and deaths from these prescription drugs, with some of the worst statistics in the poorest areas of the country. What is my right hon. Friend doing to reverse this worrying trend?
Topical Questions — House of Commons, 2019-03-26
Topic: Health
Matthew John David Hancock (Conservative, Centre-right): My right hon. Friend is absolutely right to raise this. There has been a rise in opioid-related deaths, and we need to work across Government to tackle the problem. Public Health England is reviewing prescription drug dependence, including opioid dependence, and we recently announced a review of over-prescription in the NHS to make sure patients are taking the right medicines for the right amount of time.
Topical Questions — House of Commons, 2019-03-26
Topic: Health
Caroline Julia Dinenage (Conservative, Centre-right): The NHS long-term plan has made it clear that learning disability and autism are one of the key clinical pillars in its absolute priorities. This transforming care work is incredibly important. Where people need access to in-patient services for assessment and treatment of their needs, it has to be for as short a time as possible, it has to be as close to home as possible and it has to be with a very clear discharge plan in place.
Topical Questions — House of Commons, 2019-03-26
Topic: Health
Questions: We all know that early intervention is vital for the most fatal mental health disorders: eating disorders. I warmly welcome how ambitious this Government have been to ensure that under-19s get seen as quickly as possible, and I encourage them to expand it. My constituents in Scotland do not have that, and they still have to wait up to 18 weeks to be seen. The Scottish Government refuse to see me, and they refuse to come in line with the UK Government. Will the Secretary of State assure me he will push this case next time he meets his counterpart in Scotland?
Matthew John David Hancock (Conservative, Centre-right): I will certainly do that, and I am very surprised and disappointed to hear what my hon. Friend has to report. I pay tribute to her work in leading on this agenda, including setting up the all-party parliamentary group. She has campaigned hard to get the Scottish Government to act. Given the progress we have made on the target—by 2021, 95% of children and young people with an eating disorder receiving treatment within one week for urgent cases and four weeks for routine cases—we are on track to meet it. That is something we should be discussing, at the very least, with our Scottish colleagues.
Topical Questions — House of Commons, 2019-03-26
Topic: Health
Questions: We all know that early intervention is vital for the most fatal mental health disorders: eating disorders. I warmly welcome how ambitious this Government have been to ensure that under-19s get seen as quickly as possible, and I encourage them to expand it. My constituents in Scotland do not have that, and they still have to wait up to 18 weeks to be seen. The Scottish Government refuse to see me, and they refuse to come in line with the UK Government. Will the Secretary of State assure me he will push this case next time he meets his counterpart in Scotland?; My constituency hosts world-pioneering hubs of medical innovation that have allowed many patients across the UK and beyond to benefit from cutting-edge treatments like endovascular repair for abdominal aortic aneurysms. What work is the Department planning to undertake to maintain patient access to this highly effective treatment and to foster continued healthcare innovation?
Matthew John David Hancock (Conservative, Centre-right): We have a range of work going on to improve access to innovative new treatments, both pharmaceutical treatments and the broader treatments that the hon. Gentleman describes, including ensuring, through an accelerated access collaborative led by the former Labour Minister Lord Darzi, that we drive innovation and that those innovations are taken up by other parts of the NHS.